angiotensin ii has been researched along with isorhapontigenin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, DL; Huang, Y; Hui, RT; Li, HL; Liang, CC; Lin, M; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Williams, GM; Zhang, CN | 1 |
1 other study(ies) available for angiotensin ii and isorhapontigenin
| Article | Year |
|---|---|
Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Blotting, Western; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Enzyme Activation; Free Radicals; Glutathione Peroxidase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Ventricles; Hydrogen Peroxide; L-Lactate Dehydrogenase; Leucine; Lipid Peroxidation; Malondialdehyde; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Chemical; Myocytes, Cardiac; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Superoxide Dismutase; Time Factors; Transcription Factor AP-1 | 2005 |